101 related articles for article (PubMed ID: 8612763)
1. Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase.
Izawa I; Tamaki N; Saya H
FEBS Lett; 1996 Mar; 382(1-2):53-9. PubMed ID: 8612763
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of neurofibromin by cAMP-dependent protein kinase is regulated via a cellular association of N(G),N(G)-dimethylarginine dimethylaminohydrolase.
Tokuo H; Yunoue S; Feng L; Kimoto M; Tsuji H; Ono T; Saya H; Araki N
FEBS Lett; 2001 Apr; 494(1-2):48-53. PubMed ID: 11297733
[TBL] [Abstract][Full Text] [Related]
3. PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.
Feng L; Yunoue S; Tokuo H; Ozawa T; Zhang D; Patrakitkomjorn S; Ichimura T; Saya H; Araki N
FEBS Lett; 2004 Jan; 557(1-3):275-82. PubMed ID: 14741381
[TBL] [Abstract][Full Text] [Related]
4. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
[TBL] [Abstract][Full Text] [Related]
5. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W
Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530
[TBL] [Abstract][Full Text] [Related]
6. Restoring functional neurofibromin by protein transduction.
Mellert K; Lechner S; Lüdeke M; Lamla M; Möller P; Kemkemer R; Scheffzek K; Kaufmann D
Sci Rep; 2018 Apr; 8(1):6171. PubMed ID: 29670214
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.
Brown JA; Diggs-Andrews KA; Gianino SM; Gutmann DH
Mol Cell Neurosci; 2012 Jan; 49(1):13-22. PubMed ID: 21903164
[TBL] [Abstract][Full Text] [Related]
8. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of neurofibromin in the soft tissue tumours obtained from patients with neurofibromatosis type I.
Takahashi K; Suzuki H; Hatori M; Abe Y; Kokubun S; Sakurai M; Shibahara S
Clin Sci (Lond); 1995 May; 88(5):581-5. PubMed ID: 7614817
[TBL] [Abstract][Full Text] [Related]
10. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
[TBL] [Abstract][Full Text] [Related]
11. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
[TBL] [Abstract][Full Text] [Related]
12. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I.
Gutmann DH; Cole JL; Stone WJ; Ponder BA; Collins FS
Genes Chromosomes Cancer; 1994 May; 10(1):55-8. PubMed ID: 7519874
[TBL] [Abstract][Full Text] [Related]
13. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue JE; Cohen BD; Lowy DR
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9914-8. PubMed ID: 1946460
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells.
Mangoura D; Sun Y; Li C; Singh D; Gutmann DH; Flores A; Ahmed M; Vallianatos G
Oncogene; 2006 Feb; 25(5):735-45. PubMed ID: 16314845
[TBL] [Abstract][Full Text] [Related]
17. Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression.
Koliou X; Fedonidis C; Kalpachidou T; Mangoura D
J Neurochem; 2016 Jan; 136(1):78-91. PubMed ID: 26490262
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.
Anastasaki C; Woo AS; Messiaen LM; Gutmann DH
Hum Mol Genet; 2015 Jun; 24(12):3518-28. PubMed ID: 25788518
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.
Gregory PE; Gutmann DH; Mitchell A; Park S; Boguski M; Jacks T; Wood DL; Jove R; Collins FS
Somat Cell Mol Genet; 1993 May; 19(3):265-74. PubMed ID: 8332934
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.
Gutmann DH; Tennekoon GI; Cole JL; Collins FS; Rutkowski JL
J Neurosci Res; 1993 Oct; 36(2):216-23. PubMed ID: 7505343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
